Day

October 26, 2022

26
Oct
2022

Biotech Executives Call for Action on Reproductive Health Rights

Dear Friends and Biopharma colleagues,  The rapidly approaching midterm elections carry the potential to dramatically reshape the political landscape in myriad ways. The importance of the US Supreme Court’s Dobbs decision in June, overturning Roe v. Wade, looms large.  At this critical time, we must be clear that Dobbs was about more than abortion.  With the decision to eliminate a...
Read More